Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998293722> ?p ?o ?g. }
- W2998293722 endingPage "268" @default.
- W2998293722 startingPage "261" @default.
- W2998293722 abstract "Adverse Drug Reactions Associated with CYP 2B6 Polymorphisms in HIV/AIDS-Treated Patients in Yaounde, Cameroon Carine Nguefeu Nkenfou,1,2 Barbara Atogho Tiedeu,1,2 Celine Nguefeu Nkenfou,3–5 Akindeh M Nji,1,2 Jean Paul Chedjou,1,2 Calvino Tah Fomboh,2,6 Charles Kouanfack,7,8 Wilfred F Mbacham1,2,91Department of Biochemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon; 2The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon; 3Systems Biology, Chantal Biya’ International Reference Centre for Research on HIV and AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon; 4Department of Biology, Higher Teachers’ Training College, University of Yaoundé I, Yaoundé, Cameroon; 5Molecular Biology Center Yaoundé, Yaoundé, Cameroon; 6Catholic University of Yaoundé (UCAC), Yaoundé, Cameroon; 7Day Care Unit, Central Hospital Yaoundé, Yaoundé, Cameroon; 8Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; 9Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonCorrespondence: Wilfred F MbachamLaboratory for Public Health Research Biotechnologies, Biotechnology Center (BTC), P.O. Box 3851, Nkolbisson, Yaounde, CameroonTel +237-677579180Email wfmbacham@yahoo.comPurpose: The metabolism of antiretroviral drugs is subject to individual variations of the CYP 2B6 gene. The objective of this study was to evaluate the prevalence of CYP 2B6 516 G>T and 983 T>C polymorphisms and investigate their association with the development of adverse drug reactions (ADRs) in people living with HIV/AIDS in Cameroon.Patients and methods: A total number of 122 patients, attending the Yaoundé Central Hospital HIV Day Clinic, consented to take part in this study. Blood specimens were collected and DNA was extracted using the Chelex method. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) was performed for the detection of CYP 2B6 Single-Nucleotide Polymorphisms (SNPs). Genotype frequencies were compared between groups with or without ADRs. Logistic regression analysis was performed to assess association between genotype and adverse effects of antiretroviral therapy (ART).Results: Three types of metabolizers were identified: extensive, intermediate and slow. For the 516G>T polymorphism, prevalences of 8.2% GG, 65.6% GT and 26.2% TT were obtained. For the 983T>C polymorphism, 89.3% TT, 4.1% CT and 6.6% CC prevalences were obtained. Those homozygous for the wild-type allele (516GG) were less likely to develop ADR with a statistically significant difference (OR=0.885, P=0.029). For the CYP2B6 T983C SNP, homozygous mutants (CC) may present a higher risk (threefold) of developing adverse reactions (OR=2.677, P=0.164).Conclusion: These findings demonstrate that ADRs among HIV/AIDS patients under ART may be associated with the genetic variability of the metabolizing enzyme CYP 2B6. Genotyping for this gene may guide the better administration of Efavirenz and Nevirapine to Cameroonian patients.Keywords: CYP 2B6 polymorphisms, association, adverse drug reactions, HIV/AIDS" @default.
- W2998293722 created "2020-01-10" @default.
- W2998293722 creator A5013575025 @default.
- W2998293722 creator A5016318683 @default.
- W2998293722 creator A5018262008 @default.
- W2998293722 creator A5023778657 @default.
- W2998293722 creator A5041902919 @default.
- W2998293722 creator A5056093448 @default.
- W2998293722 creator A5068770175 @default.
- W2998293722 creator A5077442227 @default.
- W2998293722 date "2019-12-01" @default.
- W2998293722 modified "2023-10-03" @default.
- W2998293722 title "<p>Adverse Drug Reactions Associated with CYP 2B6 Polymorphisms in HIV/AIDS-Treated Patients in Yaoundé, Cameroon</p>" @default.
- W2998293722 cites W1526621050 @default.
- W2998293722 cites W1531424682 @default.
- W2998293722 cites W1838568970 @default.
- W2998293722 cites W1987178620 @default.
- W2998293722 cites W2001435229 @default.
- W2998293722 cites W2008043506 @default.
- W2998293722 cites W2012459259 @default.
- W2998293722 cites W2014983717 @default.
- W2998293722 cites W2029859187 @default.
- W2998293722 cites W2036641108 @default.
- W2998293722 cites W2049761843 @default.
- W2998293722 cites W2050781209 @default.
- W2998293722 cites W2051793219 @default.
- W2998293722 cites W2054308151 @default.
- W2998293722 cites W2059767880 @default.
- W2998293722 cites W2071086973 @default.
- W2998293722 cites W2072873500 @default.
- W2998293722 cites W2075051244 @default.
- W2998293722 cites W2086199174 @default.
- W2998293722 cites W2099448528 @default.
- W2998293722 cites W2101659441 @default.
- W2998293722 cites W2108835974 @default.
- W2998293722 cites W2110868212 @default.
- W2998293722 cites W2125675654 @default.
- W2998293722 cites W2126546063 @default.
- W2998293722 cites W2130177272 @default.
- W2998293722 cites W2135826395 @default.
- W2998293722 cites W2147458465 @default.
- W2998293722 cites W2150798963 @default.
- W2998293722 cites W2162859654 @default.
- W2998293722 cites W2164216849 @default.
- W2998293722 cites W2169932466 @default.
- W2998293722 cites W2176035305 @default.
- W2998293722 cites W2252575358 @default.
- W2998293722 cites W2323214475 @default.
- W2998293722 cites W2329526205 @default.
- W2998293722 cites W2332787577 @default.
- W2998293722 cites W2475857717 @default.
- W2998293722 cites W2585662290 @default.
- W2998293722 cites W2768680992 @default.
- W2998293722 doi "https://doi.org/10.2147/tacg.s226318" @default.
- W2998293722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6941599" @default.
- W2998293722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31920362" @default.
- W2998293722 hasPublicationYear "2019" @default.
- W2998293722 type Work @default.
- W2998293722 sameAs 2998293722 @default.
- W2998293722 citedByCount "3" @default.
- W2998293722 countsByYear W29982937222021 @default.
- W2998293722 countsByYear W29982937222022 @default.
- W2998293722 crossrefType "journal-article" @default.
- W2998293722 hasAuthorship W2998293722A5013575025 @default.
- W2998293722 hasAuthorship W2998293722A5016318683 @default.
- W2998293722 hasAuthorship W2998293722A5018262008 @default.
- W2998293722 hasAuthorship W2998293722A5023778657 @default.
- W2998293722 hasAuthorship W2998293722A5041902919 @default.
- W2998293722 hasAuthorship W2998293722A5056093448 @default.
- W2998293722 hasAuthorship W2998293722A5068770175 @default.
- W2998293722 hasAuthorship W2998293722A5077442227 @default.
- W2998293722 hasBestOaLocation W29982937221 @default.
- W2998293722 hasConcept C138816342 @default.
- W2998293722 hasConcept C159110408 @default.
- W2998293722 hasConcept C29456083 @default.
- W2998293722 hasConcept C3013748606 @default.
- W2998293722 hasConcept C512399662 @default.
- W2998293722 hasConcept C71924100 @default.
- W2998293722 hasConceptScore W2998293722C138816342 @default.
- W2998293722 hasConceptScore W2998293722C159110408 @default.
- W2998293722 hasConceptScore W2998293722C29456083 @default.
- W2998293722 hasConceptScore W2998293722C3013748606 @default.
- W2998293722 hasConceptScore W2998293722C512399662 @default.
- W2998293722 hasConceptScore W2998293722C71924100 @default.
- W2998293722 hasLocation W29982937221 @default.
- W2998293722 hasLocation W29982937222 @default.
- W2998293722 hasLocation W29982937223 @default.
- W2998293722 hasLocation W29982937224 @default.
- W2998293722 hasOpenAccess W2998293722 @default.
- W2998293722 hasPrimaryLocation W29982937221 @default.
- W2998293722 hasRelatedWork W1495146225 @default.
- W2998293722 hasRelatedWork W1973460911 @default.
- W2998293722 hasRelatedWork W2096903645 @default.
- W2998293722 hasRelatedWork W2270439718 @default.
- W2998293722 hasRelatedWork W2799626806 @default.
- W2998293722 hasRelatedWork W3085296700 @default.
- W2998293722 hasRelatedWork W4205329232 @default.
- W2998293722 hasRelatedWork W4236801254 @default.